international pharmaceutical and medicinal publications ...united states pharmacopeia 42 national...
TRANSCRIPT
International Pharmaceutical and Medicinal Publications Catalogue 2019
Featuring publications from:
FREE SHIPPING on all U.S.
and European Pharmacopoeia
orders
The British Pharmacopoeia 2020The British Pharmacopoeia (BP) 2020 supersedes the BP 2019 and becomes legally effective on 1 January 2020.
The BP is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
The complete package includes a printed edition, an online licence and a download for use when offline; but other formats and bundles are available to ensure you get the best value access to the information you need.
Add the BP Archive option to your standard package and receive online access to all the BP editions from 2014 to date. The Archive is a useful tool that enables you to switch between different versions of a monograph by publication to help users track what’s changed.
Author: The British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare products Regulatory Agency (MHRA)
Publisher: TSO (The Stationery Office)
New for the BP 2020
• 35 new BP monographs, 40 new Ph. Eur. monographs
• 331 amended BP monographs
• Five new monographs for unlicensed formulations, two new monographs for herbal medicines
• One new and one amended BP Veterinary monographs
• All monographs from the Ph. Eur. 9th Edition including Supplements 9.1 to 9.8
• Three in-year online and offline download product updates to integrate the Ph. Eur. Supplements 10.0, 10.1 and 10.2
Products Format ISBN/SUB NO PriceComplete Package Six-volume printed edition
Single-user* online licence
Single-user* download for offline use
9780113230761 £1,000
Hard Copy Six-volume printed edition 9780113230778 £875
Single-User Licence (SUL) Single-user online licence* 7005117 £875 (£1,050 inc. VAT)
SUL + BAN Single-user online licence* 7005118 £1,025 (£1,230 inc. VAT)
SUL + Archive Single-user online licence* 7005119 £1,075 (£1,290 inc. VAT)
SUL + BAN + Archive Single-user online licence* 7005120 £1,225 (£1,470 inc. VAT)
Download Single-user download* 9780113230785 £875 (£1,050 inc. VAT)* These single-user licences are granted solely to the designated holder of the product within an organisation. Multi-user licences are available.
Contact: [email protected] or call +44 (0)1603 696675 to discuss your requirements
British Pharmacopoeia Multi-User LicencesFor access across your organisation
A British Pharmacopoeia multi-user licence will provide you with:
• A flexible licence tailored to your organisation’s requirements
• Simultaneous access across workstations, laptops and other portable devices
• Access to the full text of the BP, including Veterinary and Herbal standards
• Access to the three in-year updates to harmonise with the European Pharmacopoeia Supplements
• Instant online access via IP recognition
Author: The British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare products Regulatory Agency (MHRA)
Publisher: TSO (The Stationery Office)
British Approved Names (BAN) 2017 & BAN 2017 Supplements No. 1, 2 & 3The British Approved Names (BAN) is the official dictionary of names for UK medicinal substances. British Approved Names are short, distinctive names for substances for which the systematic chemical or other scientific names are too complex for convenient general use. The BAN makes an important contribution to public health by ensuring that names selected are unique. The BAN is an essential reference for all individuals and organisations working within pharmaceutical research, manufacture and regulatory affairs.
Key features
• Special attention to biological and biotechnological substances
• Key to pronunciation, symbols and abbreviations
• Cross-reference index of British Approved Names and Proprietary Names
• Guidelines for pharmaceutical trade marks
• Discontinued substances and products listed
Products Format ISBN PriceBAN 2017 Print A4 Hardback 9780113230334 £150
BAN 2017 Supplement No. 1 Print A4 Hardback 9780113230594 £20
BAN 2017 Supplement No. 2 Print A4 Hardback 9780113230723 £20
BAN 2017 Supplement No. 3 Print A4 Hardback 9780113230792 £20
Ask usabout adding
access to the BP
online archive to
your subscription
Online access has revolutionised the way in which BP is accessed within our company. We find that it provides a really user-friendly and efficient way of navigating the content, and the multi-user licence enables our entire company to have access at a really cost-effective price.
Ashleigh GordonAesica Pharmaceuticals Ltd
Author and Publisher: European Pharmacopoeia Commission, Council of Europe European Directorate for the Quality of Medicines (EDQM)
European Pharmacopoeia 10th EditionThe European Pharmacopoeia (EP) is a single reference work for the quality control of medicines in Europe. All producers of medicines or substances for pharmaceutical use must apply the quality standards of the European Pharmacopoeia for the marketing and use of these products in Europe.
The EP outlines preparations for pharmaceutical use of chemical, animal, human or herbal origin. It also covers biologicals, blood and plasma derivatives, vaccines and radiopharmaceutical preparations. The monographs give quality standards for all the main medicines used in Europe.
The European Pharmacopoeia is supplied as a subscription to ensure that subscribers receive all three issues of their purchase. Print supplements are non-cumulative and therefore all previous issues of an edition are required.
The new Electronic version provides access until 31st December 2020 to the content of 10.0 and the first 2 cumulative updates, 10.1 and 10.2, as well as to the Ph. Eur. online archives and direct access to complementary information (Knowledge Database).
A single licence provides named user access to one named person along with the ability to download an application for online and offline use to 1 computer* and 1 USB stick.
* fully compatible with recent Windows and Linux operating systems (Mac coming soon)
Contact our Sales TeamGet in touch with the TSO sales team to see how we could work to support both you and your markets with pharmaceutical publications.For individual purchases, please contact the sales team on: Tel: 01603 696860 Email: [email protected]
For Multi-User licence enquiries, please contact: Subscriptions Sales Manager, Nichol Pope +44 (0)1603 696675 [email protected]
For information on our great discount rates for resellers, please contact: Export Sales Manager, Thomas Wheeler +44 (0)1603 696811 [email protected]
Products Format ISBN/SUB NO Price
European Pharmacopoeia 10th Edition (includes Supplements 10.1 & 10.2)
Print 7704059 £510
European Pharmacopoeia 10th Edition Electronic 9789999146111 £510 (£612 inc. VAT)
Author and Publisher: United States Pharmacopeial Convention
SUB NO: 7701103
Price: £330 (£396 inc. VAT)
Format: Online annual subscription
USP dictionary of USAN and International Drug Names 2018The USP Dictionary of United States Adopted Names (USAN) and International Drug Names is the leading reference for nonproprietary drug names and chemical structures. In addition to USANs, the USP Dictionary provides International Nonproprietary Names (INNs), British Approved Names, Japanese Accepted Names, brand names, Unique Ingredient Identifier (UNII) codes, manufacturers, official USP-NF names, molecular weights, graphic formulas, pharmacologic and/or therapeutic categories, and pronunciations.
United States Pharmacopeia 42 National Formulary 37The USP-NF is a combination of two compendia, the United States Pharmacopeia (USP) and the National Formulary (NF). It contains standards for medicines, dosage forms, drug substances, excipients, biologics, compounded preparations, medical devices, dietary supplements, and other therapeutics.
USP 42 - NF 37 is in force from 1st May 2019. It will be enforceable by the U.S. Food and Drug Administration for medicines manufactured and marketed in the United States.
Includes a four-volume print main edition and two separate print supplements. Printed on thick, durable paper stock, for laboratory and manufacturing use. Each volume contains a complete table of contents and index. Shipped with a slipcase for easy access and storage.
Author and Publisher: United States Pharmacopeial Convention
Formats SUB NO PricePrint 7701037 £950
Online 7701011 £820 (£984 inc. VAT)
USB 7701038 £950 (£1,140 inc. VAT)
USP 43 NF 38
publishing
October2019
United States Pharmacopeia Dietary Supplements Compendium 2019A definitive resource for dietary supplement manufacturers and ingredient suppliers.
Step-by-step procedures and assays help you demonstrate that your raw materials and finished dietary supplement products meet established specifications for identity, strength, quality, purity, packaging and labeling.
Your 2019 Dietary Supplements Compendium (DSC) is the go-to source for monographs, regulatory guidances, and reference tools for the dietary supplement supply chain. It will be available online only and includes 24 additional General Chapters, 72 new monographs, 59 updated HPTLC plates, and more!
This is an annual subscription from the date of purchase.
Food Chemicals Codex (FCC) 11th EditionThe FCC is a compendium of internationally recognized standards for determining the purity and quality of food ingredients. It is a valuable resource for authenticating a wide variety of ingredients, including processing aids, preservatives, flavorings, colorants, and nutrients.
The subscription includes a main edition and three supplements, which publish at six-month intervals during the subscription period. Each supplement contains significant new and revised standards and information. The prices shown below are for a two-year subscription inclusive of all supplement updates to the main edition.
Formats SUB NO PricePrint 7701101 £950
Online 7701102 £560 (£672 inc. VAT)
Author and Publisher: United States Pharmacopeial Convention
Author and Publisher: United States Pharmacopeial Convention
ISBN: 9789999149785
Price: £150 (£180 inc. VAT)
Format: Online Licence
Japanese Pharmacopoeia 17th Edition - English TranslationThe Japanese Pharmacopoeia 17th edition (JP XVII) English translation is fully endorsed by the society of the Japanese Pharmacopoeia. It defines the specifications, criteria and standard test methods necessary to properly ensure the quality of medicines in Japan. The Japanese language edition was effective from 1st April 2016.
New for this edition:
• Revised and expanded General Notices, General Rules for Crude Drugs and General Rules for Preparations
• 76 new monographs and 473 revised monographs
• General tests, processes and apparatus: 23 new standards and 10 revised standards
• Infrared reference spectra: 21 new spectra and 2 revised spectra
• Ultraviolet-visible reference spectra: 14 new spectra and 2 revised spectra
Chinese Pharmacopoeia 2015 Edition - English TranslationThe Pharmacopoeia of the People’s Republic of China 2015 Edition is the 10th edition of the Chinese Pharmacopoeia. It covers both traditional Chinese medicines and western medicines. It gives descriptions and information on the standards of purity, testing, dosage, precautions, storage, and the strength of each drug.
This 2015 edition provides the statutory requirements for foreign pharmaceutical companies producing medicines for the Chinese market. It came into effect on 1st December 2015.
The Chinese Pharmacopoeia 2015 edition comprises Volumes I, II, III and IV and contains a total of 5,608 types of medicinal product, including 1,082 new revisions.
Volume IV is new to this edition. Various appendices of the previous edition of the pharmacopoeia have been consolidated into the Volume IV of this edition of the pharmacopoeia.
Formats ISBN PricePrint 9787506789295 £770
USB 9780118987660 £695 (£834 inc. VAT)
Formats ISBN PricePrint 9784840813716 £795
Supplement 1 9784840814768 £195
German Homeopathic Pharmacopoeia (GHP) 2019 – Including 15th SupplementThis updated edition has been translated into the English language, making this widely acclaimed work available to the global community of:• Homoeopathic manufacturers
• Homoeopathic physicians
• Non-medical practitioners
• Pharmacists and
• National registration authorities
Professionals engaged in all aspects of the manufacture, evaluation, registration or dispensing of homoeopathic substances or medicinal products now have access to a wealth of information comprising approximately 600 monographs and general texts including reagents, vehicles and excipients analytical and the very important manufacturing methods. Homoeopathic and anthroposophical manufacturing methods are included as well as the methods used in spagyrics and the production of organ-derived preparations. The analytical methods have been harmonized with the European Pharmacopoeia (Ph. Eur.) and the German Pharmacopoeia (DAB).
The loose-leaf format makes it easy for the user to keep this collection up to date.
Author and Publisher: Medpharm Scientific Publishers
ISBN: 9783804750814
Price: £445
Format: Looseleaf with binder holes
Extent: 2318pp
Formats SUB NO PricePrint 9783804750814 £445
Indian Pharmacopoeia 2018The eighth edition of the Indian Pharmacopoeia (IP - 2018) has been brought out in four volumes incorporating:• 170 new chemical monographs
• 15 new herbal monographs
• 3 new radiopharmaceutical monographs
• 14 new veterinary monographs
• 18 new biological monographs
• 366 revised monographs
• 7 omissions
Standards for new drugs and drugs used under National Health Programmes are included, and 53 new Fixed Dose Combination (FDC) monographs have been included, 25 of which are unavailable in any other pharmacopoeia.
Author and Publisher: Indian Pharmacopoeia Commission
ISBN: 9789381238196
Price: £1,050
Format: Hardback
Extent: Four volumes
Author: British Medical Association, Royal Pharmaceutical Society of Great Britain
Publisher: BMJ Publishing Group Ltd and Royal Pharmaceutical Society
ISBN: 9780857113436
Price: £59.95
Format: Paperback 210 x 148mm
Extent: 1600pp
Author: British Medical Association, Royal Pharmaceutical Society of Great Britain
Publisher: BMJ Publishing Group Ltd and Royal Pharmaceutical Society
ISBN: 9780857113368
Price: £57.50
Format: Paperback 210 x 148mm
Extent: 1600pp
British National Formulary: 77 (March 2019)Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, the new edition of the British National Formulary 77 (BNF) provides up-to-date guidance on prescribing, dispensing, and administering medicines. Access to the latest edition of the BNF is vital for healthcare professionals, as it reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.
BNF for Children (BNFC) 2018-2019The BNF for Children (BNFC) 2018-2019 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children. It addresses a significant knowledge gap in many areas of paediatric practice by providing practical information on the use of medicines in children of all ages from birth to adolescence.
Recommendations in the BNFC have been constructed on the basis of authoritative sources, emerging evidence and best practice guidelines. The content has been carefully validated by a network of paediatric experts and the process is overseen by a paediatric formulary committee.
The BNF for Children 2018-2019 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice.
Author: Royal Pharmaceutical Society
Publisher: Pharmaceutical Press
ISBN: 9780857113092
Price: £550
Format: Hardback 276 x 219mm
Extent: Two volumes
Martindale: The Complete Drug Reference 39th editionThe Complete Drug Reference provides unbiased and evaluated information on drugs and medicines in use around the world.
It is prepared by an experienced team of pharmacists and life scientists who use their professional expertise to select the most clinically relevant and appropriate information from reliable published sources, to provide an unbiased and evaluated digest of the literature.
It contains:
• Over 6,300 drug monographs
• Over 185,000 preparations
• Nearly 700 treatment reviews, with references from the published literature
• Information to help you identify medicines, the local equivalent and the manufacturer
• Herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins and poisons
Author: Ivan H. Stockley
Publisher: Pharmaceutical Press
ISBN: 9780857113474
Price: £240
Format: Hardback 276 × 219 mm
Extent: 2048pp
Stockley’s Drug Interactions Stockley’s Drug Interactions, edited by Claire L Preston, remains the world’s most comprehensive and authoritative international reference book on drug interactions. Based upon thousands of published papers and reports it:• Covers interactions between therapeutic drugs, proprietary
medicines, herbal medicines, foods, drinks, and drugs of abuse
• Contains in-depth yet concise monographs in an easy-to-read format
• Provides comprehensive details of the clinical evidence for the interactions under discussion, an assessment of their clinical importance, and clear guidance on managing the interaction in practice
• Has a brief summary of the interaction in each monograph – perfect for the busy healthcare professional
• Is fully referenced throughout
• Is global in coverage
Author: MHRA
Publisher: Pharmaceutical Press
ISBN: 9780857112859
Price: £80
Format: Paperback 244 x 172mm
Extent: 806pp
Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2017 The Orange GuideThis is the tenth edition of Rules and Guidance for Pharmaceutical Manufacturers and Distributors, compiled by MHRA. Commonly known as the Orange Guide, it remains an essential reference for all manufacturers and distributors of medicines
in Europe. It provides a single authoritative source of European and UK guidance, information and legislation relating to the manufacture and distribution of human medicines.
The new 2017 edition has been updated to incorporate changes and additions made to the detailed European Community guidelines on Good Manufacturing Practice (GMP) and the revised EU Guidelines on Good Distribution Practice (GDP), including Annexes 15 and 16.
Good Clinical Practice GuideThis detailed and authoritative guide covers the legislation, guidance and good practice that relates to the conduct of clinical trials of medicinal products for human use in the UK. It references European and international standards so will also be relevant to organisations conducting trials across Europe and beyond.
Written and produced by the MHRA, this is the only guide on Good Clinical Practice available within Europe which has been produced by a regulatory agency.
Author: MHRA
Publisher: Pharmaceutical Press
ISBN: 9780117081079
Price: £45
Format: Paperback 244 x 172mm
Extent: 542pp
Rules and Guidance for Pharmaceutical Distributors 2017 The Green GuideThis new 2017 edition provides you with a single source of guidance to, and legislation for, the distribution of medicines in Europe and the UK. This tenth edition has been updated to incorporate the revised EU Guidelines on Good Distribution Practice.
The Green Guide reproduces all the elements of the new Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2017 (the Orange Guide) that are relevant to distributors. So if you’re involved in the wholesale supply, distribution and brokering of medicines for human use and the distribution of active substances, this is the one-stop guide you need.
Author: MHRA
Publisher: Pharmaceutical Press
ISBN: 9780857112866
Price: £70
Format: Paperback 244 x 172mm
Extent: 336pp
